Corporate villains are sometimes behind sudden increases in drug prices, but these unwanted surprises are often the result of a complicated and opaque healthcare system. The FT's David Crow joins Cardiff Garcia and Mary Childs to discuss in this snack-sized episode of the weekly podcast. Visit FT.com/Alphachat for show notes and links.

iTunes Stitcher audioBoom SoundCloud Overcast RSS


Copyright The Financial Times Limited 2017. All rights reserved.
myFT

Follow the topics related to this show

Comments have not been enabled for this podcast.